- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04283123
Feasibility of an Automated Bidet Intervention to Decrease Caregiver Burden
Evaluating the Feasibility of an Automated Bidet Intervention to Decrease Caregiver Burden
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Informal caregivers provide over 30 billion hours of care to older adults each year. They often assist with toileting tasks which are often identified as one of the most physically and emotionally demanding activities of daily living. Caregivers receive limited training and support which increases their risk for injury and burnout. One potential strategy to reduce or replace the physical support needed from a caregiver is the used of an automated bidet system. It remains unknown whether an automated bidet can be used successfully with older adults and their caregivers at home. The objective of this feasibility study was to assess the acceptability and preliminary efficacy of a toileting intervention using an automated bidet system and training by an occupational therapy practitioner (OT) to reduce the amount of physical assistance required from caregivers.
The investigators will recruit 10 informal caregivers and randomize them to the treatment or waitlist control group. Caregivers in the treatment group will receive the automated bidet right away while those in the waitlist control group will not receive any treatment during that time. After 30 days, both groups will participate in a post-test assessment visit. The waitlist control group will then be offered the intervention and invited to participate in a final session after 30 days to complete assessments and a process evaluation (30 days post follow-up).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- (1) provided unpaid care and lived with a care recipient aged 55 years or older
- (2) assisted with toileting for at least 6 months
- (3) did not have an automated bidet
- (4) had a working toilet and bathroom outlet, and (5) their care recipient was willing to participate
Exclusion Criteria:
- Caregivers scoring 10 or above on the Short Blessed Test, indicating possible cognitive impairment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Treatment
Participants assigned to this group will receive an automated bidet (TOTO Washlet S300e with remote control) and an occupational therapy intervention over 3-4 in-home visits.
|
During the first intervention visit, a licensed contractor will install the bidets in participants' homes.
The OT will then educate and train the caregiver and care recipient to successfully use the bidet, and make any modifications to the remote as needed.
Throughout the intervention, the OT will use motivational enhancement strategies.
The OT will make minor modifications to the remote as needed.
A second intervention visit will occur 1-2 weeks post-installation to address any new difficulties.
Check-in phone calls will be offered to the caregiver and care recipient if needed.
|
Active Comparator: Waitlist Control
Caregivers will wait for 30 days and then will be offered the intervention.
|
Waitlist control
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of participants recruited
Time Frame: 5 months
|
Recruit 10 caregivers
|
5 months
|
Number of caregivers retained
Time Frame: At study completion (2 months [treatment] or 3 months [waitlist control])
|
Retain 10 caregivers
|
At study completion (2 months [treatment] or 3 months [waitlist control])
|
Ability to install the automated bidets, including any modifications needed
Time Frame: 30 days post-installation
|
Installation of the automated bidets and a record of any modifications needed
|
30 days post-installation
|
Caregivers' or care recipients' ability to operate the bidet
Time Frame: 30 days post-installation
|
Demonstrate ability to operate the bidet successfully
|
30 days post-installation
|
Acceptability
Time Frame: 30 days post-installation
|
8-item process evaluation: rated on a scale of 0 (strongly disagree) to 4 (strongly agree) with higher scores indicating greater acceptance of the intervention
|
30 days post-installation
|
Preliminary efficacy
Time Frame: 2 months (treatment) or 3 months (waitlist control)
|
In-Home Occupational Performance Evaluation for Providing Assistance: reduction of physical barriers to toileting (rated on a scale from 0 (independent) to 5 (no activity/dependent)], and impact on caregiver outcomes (rated on a scale of 1 to 5 with higher scores indicating better performance, satisfaction, and self-efficacy)
|
2 months (treatment) or 3 months (waitlist control)
|
Adverse events
Time Frame: At study completion (2 months [treatment] or 3 months [waitlist control])
|
Number of adverse events
|
At study completion (2 months [treatment] or 3 months [waitlist control])
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 201610044
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Caregiver Burnout
-
Wroclaw University of Health and Sport SciencesUniversity of Silesia in Katowice; Jan Dlugosz University in CzestochowaCompleted
-
University Diego PortalesInstituto de Seguridad del Trabajo, ChileRecruitingBurnout | Burnout, Caregiver | Parental BurnoutChile
-
Memorial Sloan Kettering Cancer CenterRecruitingCaregiver Burden | Caregiver Stress Syndrome | Caregiver BurnoutUnited States
-
Indonesia UniversityCompleted
-
Hamad Medical CorporationCompletedIntensive Care Unit | Extracorporeal Membrane Oxygenation Complication | Burnout, CaregiverQatar
-
Consuelo Lourdes Díaz RodríguezCompleted
-
Istanbul Saglik Bilimleri UniversityCompleted
-
Medical University of South CarolinaUniversity of DelawareCompletedBurnout, CaregiverUnited States
-
Melanie KeatsNot yet recruiting
-
Charite University, Berlin, GermanySuspendedBurnout, Professional | Mental Disorder | Burnout, CaregiverGermany
Clinical Trials on Automated Bidet
-
Seoul National University HospitalWoongjin Coway CorporationCompletedAnorectal PhysiologyKorea, Republic of
-
Seoul National University HospitalCoway Research and Development CenterCompletedAnorectal DisordersKorea, Republic of
-
Seoul National University HospitalDaehang Hospital; Coway CoUnknown
-
Stanford UniversityTerminatedToileting in Adults With Impaired Functional Status | Caregiver Burden for Those Who Care for Adults With Impaired Functional Status | UTI in Adults With Impaired Functional StatusUnited States
-
Bruyere Research InstituteUniversity of Ottawa; Bruyere Academic Medical Organization; TOTO USAUnknown
-
Hopital FochRecruitingSpinal Cord InjuriesFrance
-
Regenstrief Institute, Inc.Merck Sharp & Dohme LLC; Indiana UniversityCompletedCervical Cancer | Oropharyngeal Cancer | Genital Warts | Human Papilloma Virus Infection Type 11 | Human Papilloma Virus Infection Type 16 | Human Papilloma Virus Infection Type 18 | Human Papilloma Virus Infection Type 6
-
Duke UniversityDuke Institute for Health InnovationTerminatedHypertension | Cancer | Blood Pressure | Cancer, Breast | CLL | Cancer of Prostate | Hematopoietic MalignancyUnited States
-
Tempus AIMedtronicNot yet recruiting
-
Centre Hospitalier Intercommunal de Toulon La Seyne...Hamilton Medical AGRecruitingAcute Respiratory FailureFrance